» Articles » PMID: 29222945

Children with Atopic Dermatitis May Have Unacknowledged Contact Allergies Contributing to Their Skin Symptoms

Overview
Date 2017 Dec 10
PMID 29222945
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Whether children with atopic dermatitis have an altered risk of contact allergy than children without atopic dermatitis is frequently debated and studies have been conflicting. Theoretically, the impaired skin barrier in atopic dermatitis (AD) facilitates the penetration of potential allergens and several authors have highlighted the risk of underestimating and overlooking contact allergy in children with atopic dermatitis.

Objective: To determine the prevalence of contact allergy in Danish children with atopic dermatitis and explore the problem of unacknowledged allergies maintaining or aggravating the skin symptoms.

Methods: In a cross-sectional study, 100 children and adolescents aged 5-17 years with a diagnosis of atopic dermatitis were patch tested with a paediatric series of 31 allergens.

Results: Thirty per cent of the children had at least one positive patch test reaction, and 17% had at least one contact allergy that was relevant to the current skin symptoms. The risk of contact allergy was significantly correlated to the severity of atopic dermatitis. Metals and components of topical skincare products were the most frequent sensitizers.

Conclusion: Patch testing is relevant as a screening tool in the management of children with atopic dermatitis as they may have unacknowledged contact allergies contributing to or maintaining their skin symptoms. Children with atopic dermatitis seem to be at greater risk of sensitization to certain allergens including metals and components of skincare products.

Citing Articles

The evaluation of the serum levels of vitamin D and interleukin-33 in children with atopic dermatitis and its association with diseases severity.

Molatefi R, Fouladi N, Asghariazar V, Samemaleki S, Golizadeh M, Khoshlega S Arch Dermatol Res. 2025; 317(1):182.

PMID: 39775933 DOI: 10.1007/s00403-024-03709-3.


Evaluation of Patch Test Results in Paediatric Patients in a Tertiary Dermatology Clinic.

Kazan D, Odyakmaz-Demirsoy E, Eloglu H, Kiran R Indian J Dermatol. 2023; 68(3):354.

PMID: 37529441 PMC: 10389143. DOI: 10.4103/ijd.ijd_152_23.


Contact allergy in children with and without atopic dermatitis: An Italian multicentre study.

Bonamonte D, Hansel K, Romita P, Belloni Fortina A, Girolomoni G, Fabbrocini G Contact Dermatitis. 2022; 87(3):265-272.

PMID: 35451136 PMC: 9541036. DOI: 10.1111/cod.14130.


Sensitizing agents found in children and adolescents with recalcitrant atopic dermatitis: a cross-sectional study with a pediatric battery.

Cattani C, Oppermann K, Perazzoli S, Hoffmann Guarda N, Barea P, Bonamigo R An Bras Dermatol. 2022; 97(3):307-314.

PMID: 35241316 PMC: 9133262. DOI: 10.1016/j.abd.2021.08.005.


Drug survival of systemic immunosuppressive treatments for atopic dermatitis in a long-term pediatric cohort.

Elsgaard S, Danielsen A, Thyssen J, Deleuran M, Vestergaard C Int J Womens Dermatol. 2022; 7(5Part B):708-715.

PMID: 35028369 PMC: 8714597. DOI: 10.1016/j.ijwd.2021.07.005.